2019 River Blindness Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

February 2019 | 34 pages | ID: 2F3561B47CAEN
VPAResearch

Abstracts

The ongoing clinical trial research report- “2019 River Blindness Ongoing Clinical Trials Study” analyzes the current scenario of all active River Blindness trials across the world. The report presents top level analysis of global River Blindness clinical trials across countries, companies and universities. It is designed to provide clear understanding into the River Blindness trials landscape to assist users for effective long term strategy formulation to beat competition.

The report covers a key snapshot of ongoing trial count, average enrollment per trial across countries.

It also segments the River Blindness clinical trials by-

• Region (Asia Pacific, Europe, Middle East Africa and Americas)
• Countries
• Trial Phase
• Current Trial Status (Recruiting, Active, Planned, Active but Completed Recruiting, Not Yet Recruiting etc)
• Type of the trial (Interventional, Observational)
• Sponsor Type (Companies, Universities, Government Bodies etc)
• Enrollment across types, sponsor types, geographies, current status and phases

The report also identifies the potential drug candidates under development for treatment of River Blindness on the basis of intervention type ongoing River Blindness trials.

The research work is prepared through extensive and continuous research on River Blindness trials from over 150 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

REPORT SCOPE AND COVERAGE:

• All major ongoing trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering River Blindness patients are identified
• The report includes panorama of ongoing River Blindness clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on River Blindness clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 River Blindness Ongoing Clinical Trials Overview, 2019
2.2 Premium Insights into Ongoing Clinical Trials
  2.2.1 Ongoing River Blindness Clinical Trials by Region
  2.2.2 Average Enrollment of River Blindness Clinical Trials
  2.2.3 Companies participating in Ongoing Trials
  2.2.4 Drugs under Study for River Blindness Treatment, 2019

3. REGION WISE RIVER BLINDNESS CLINICAL TRIALS

3.1 Asia Pacific River Blindness Clinical Trials by Country
3.2 Europe River Blindness Clinical Trials by Country
3.3 North America River Blindness Clinical Trials by Country
3.4 Middle East and Africa River Blindness Clinical Trials by Country
3.5 South and Central America River Blindness Clinical Trials by Country

4. RIVER BLINDNESS CLINICAL TRIAL TRENDS

4.1 Start Year wise Ongoing River Blindness Clinical Trials
4.2 Phase wise Ongoing River Blindness Clinical Trials
4.3 Trial Status wise Ongoing River Blindness Clinical Trials
4.4 Trial Type wise Ongoing River Blindness Clinical Trials

5. RIVER BLINDNESS AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in River Blindness Trials by Year
5.2 Average Enrollment in River Blindness Trials by Phase
5.3 Average Enrollment in River Blindness Trials by Status
5.4 Average Enrollment in River Blindness Trials by Type of Trial

6. COMPANIES PARTICIPATING IN ONGOING RIVER BLINDNESS CLINICAL TRIALS

6.1 Ongoing River Blindness Trials by Sponsor Type
6.2 River Blindness Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Ongoing River Blindness Trials- Phase
7.2 Ongoing River Blindness Trials- Phase
7.3 Ongoing River Blindness Trials- Phase
7.4 Ongoing River Blindness Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: River Blindness Ongoing Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Ongoing River Blindness Clinical Trials and Enrolment
Figure 5: Europe – Country wise Ongoing River Blindness Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Ongoing River Blindness Clinical Trials and Enrolment
Figure 7: North America – Country wise Ongoing River Blindness Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Ongoing River Blindness Clinical Trials and Enrolment
Figure 9: River Blindness Ongoing Clinical Trials by Phase
Figure 10: River Blindness Ongoing Clinical Trials by Trial Status
Figure 11: River Blindness Ongoing Clinical Trials by Type
Figure 12: River Blindness Ongoing Clinical Trials by Sponsor Type
Figure 13: River Blindness Ongoing Clinical Trials by Leading Sponsors
Figure 14: River Blindness Average Enrollment by Phase
Figure 15: River Blindness Average Enrollment by Trial Status
Figure 16: River Blindness Average Enrollment by Type
Figure 17: River Blindness- Average Enrolment by Type of Sponsors
Figure 18: River Blindness- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: River Blindness Ongoing Clinical Trials Snapshot- 2019
Table 2: Ongoing Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Ongoing River Blindness Clinical Trials and Enrolment
Table 5: Europe – Country wise Ongoing River Blindness Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Ongoing River Blindness Clinical Trials and Enrolment
Table 7: North America – Country wise Ongoing River Blindness Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Ongoing River Blindness Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: River Blindness Average Enrollment by Phase
Table 15: River Blindness Average Enrollment by Trial Status
Table 16: River Blindness Average Enrollment by Type
Table 17: River Blindness- Average Enrolment by Type of Sponsors
Table 18: River Blindness- Enrolment by Leading Sponsors